Science Corporation's Vision-Restoring Chip Gains EU Approval
Science Corporation has received approval from Europe's medical device regulator to market its PRIMA device, a vision-restoring chip for patients with age-related macular degeneration. The device involves an outpatient procedure to implant a chip in the eye, which works with camera-equipped glasses to restore functional vision. The company is also pursuing expedited regulatory review from the U.S. FDA for treating rare blindness conditions. Science Corp. plans to offer the device in Germany, with the first procedures expected in September. The company aims to develop a sustainable business model to support further innovations in brain-computer interfaces. 
